ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/2/2025ACC: 0001415889-25-000156
Officer· Interim CFO
Since Jun 2021
-4.67K
Net shares
Net seller
$15.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.67K
Price / share
$3.35
Trade value
$15.66K
% of position
3.6%
12/31/2024
131.57K→126.89K
Total
Net shares
−4.67K
Net value
-$15.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2024 | F · Tax Withholding | −4.67K | $3.35 | $15.66K | 3.6% | 131.57K | 126.89K |
| Total | −4.67K | -$15.66K | ||||||
Derivative Transactions0
No derivative transactions reported